Growth Metrics

Dynavax Technologies (DVAX) Total Current Liabilities: 2009-2025

Historic Total Current Liabilities for Dynavax Technologies (DVAX) over the last 16 years, with Sep 2025 value amounting to $106.8 million.

  • Dynavax Technologies' Total Current Liabilities rose 52.56% to $106.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.8 million, marking a year-over-year increase of 52.56%. This contributed to the annual value of $78.6 million for FY2024, which is 26.43% up from last year.
  • Per Dynavax Technologies' latest filing, its Total Current Liabilities stood at $106.8 million for Q3 2025, which was down 9.63% from $118.2 million recorded in Q2 2025.
  • Dynavax Technologies' Total Current Liabilities' 5-year high stood at $556.4 million during Q4 2021, with a 5-year trough of $44.9 million in Q2 2023.
  • In the last 3 years, Dynavax Technologies' Total Current Liabilities had a median value of $68.4 million in 2025 and averaged $73.9 million.
  • In the last 5 years, Dynavax Technologies' Total Current Liabilities skyrocketed by 693.90% in 2021 and then slumped by 87.00% in 2023.
  • Over the past 5 years, Dynavax Technologies' Total Current Liabilities (Quarterly) stood at $556.4 million in 2021, then slumped by 73.03% to $150.1 million in 2022, then tumbled by 58.56% to $62.2 million in 2023, then grew by 26.43% to $78.6 million in 2024, then skyrocketed by 52.56% to $106.8 million in 2025.
  • Its Total Current Liabilities was $106.8 million in Q3 2025, compared to $118.2 million in Q2 2025 and $68.4 million in Q1 2025.